Perceptive Advisors Portfolio
Growth & qualityPERCEPTIVE ADVISORS LLC 13F holdings · Q3 2026 vs Q2 2026
Why growth & quality: 99 holdings, 28 effective · top 10 49% · turnover 26% a quarter · options 3% · earnings yield -6.5% (median 2.9%) · 22 Schedule 13D filings, 9% of the book · 39 quarters of 13Fs
- 13F value
- $5.3bn−17.1% vs $6.4bn in Q2 2026
- Holdings
- 85 19 new · 19 sold out
- Top 10 weight
- 49.0% Largest: PRAX 11.0%
- Bought est.
- $678m New positions and adds
- Sold est.
- $828m Trims and exits
- Quarter
- Q3 2026 Filed
Largest trades since Q2 2026
Estimated dollars: the change in shares times the quarter-end price the filing implies. Exits use last quarter's value.
| Action | Stock | Shares | Est. traded | Weight | Other gurus |
|---|---|---|---|---|---|
| New | FRNMFREENOME INC | New | +$199m | 0.0% → 3.7% | 4 |
| Trimmed | SYRESPYRE THERAPEUTICS INC | −24.0% | −$92m | 6.0% → 5.5% | 3 |
| Added | AMLXAMYLYX PHARMACEUTICALS INC | +26.9% | +$65m | 2.3% → 5.8% | 2 |
| New | WATWATERS CORP | New | +$59m | 0.0% → 1.1% | 13 |
| Trimmed | BIIBBIOGEN INC | −89.9% | −$56m | 0.9% → 0.1% | 3 |
| Sold out | IONSIONIS PHARMACEUTICALS INC | −100.0% | −$45m | 0.7% → 0.0% | — |
| New | IRDOPUS GENETICS INC | New | +$44m | 0.0% → 0.8% | 0 |
| Sold out | SIONSIONNA THERAPEUTICS INC | −100.0% | −$40m | 0.6% → 0.0% | — |
| Trimmed | UNHUNITEDHEALTH GROUP INC | −91.4% | −$39m | 0.8% → 0.1% | 27 |
| New | LKFTLAKEFRONT BIOTHERAPEUTICS NV | New | +$37m | 0.0% → 0.7% | 1 |
| Sold out | CORTCORCEPT THERAPEUTICS INC | −100.0% | −$35m | 0.5% → 0.0% | — |
| New | ABTABBOTT LABORATORIES | New | +$34m | 0.0% → 0.6% | 15 |
| New | BLSMBLOSSOMHILL THERAPEUTICS INC | New | +$34m | 0.0% → 0.6% | 1 |
| Sold out | CRLCHARLES RIV LABS INTL INC | −100.0% | −$32m | 0.5% → 0.0% | — |
| Sold out | AXSMAXSOME THERAPEUTICS INC. | −100.0% | −$29m | 0.5% → 0.0% | — |
| Trimmed | IMVTIMMUNOVANT INC | −61.7% | −$28m | 0.8% → 0.3% | 5 |
| New | MMEDMINIMED GROUP INC | New | +$26m | 0.0% → 0.5% | 1 |
| Added | NRIXNURIX THERAPEUTICS INC | +24.3% | +$25m | 1.6% → 2.4% | 3 |
| Trimmed | RLAYRELAY THERAPEUTICS INC | −9.8% | −$25m | 4.1% → 4.3% | 3 |
| Sold out | TENXTENAX THERAPEUTICS INC | −100.0% | −$25m | 0.4% → 0.0% | — |
| Trimmed | ADPTADAPTIVE BIOTECHNOLOGIES COR | −66.1% | −$23m | 0.4% → 0.2% | 1 |
| Trimmed | DYNDYNE THERAPEUTICS INC | −52.9% | −$23m | 0.9% → 0.4% | 5 |
| Trimmed | ORKAORUKA THERAPEUTICS INC | −20.3% | −$23m | 2.0% → 1.7% | 5 |
| New | SEPNSEPTERNA INC | New | +$22m | 0.0% → 0.4% | 2 |
| New | ELVNENLIVEN THERAPEUTICS INC | New | +$21m | 0.0% → 0.4% | 3 |
| Sold out | ISRGINTUITIVE SURGICAL INC | −100.0% | −$21m | 0.3% → 0.0% | — |
| Sold out | CTNMCONTINEUM THERAPEUTICS INC | −100.0% | −$21m | 0.3% → 0.0% | — |
| Trimmed | PTGXPROTAGONIST THERAPEUTICS INC | −14.8% | −$20m | 1.9% → 2.2% | 4 |
| Trimmed | RVMDREVOLUTION MEDICINES INC | −17.9% | −$19m | 1.5% → 1.7% | 8 |
| New | YARWYARROW BIOSCIENCE INC | New | +$18m | 0.0% → 0.3% | 0 |
| Sold out | OMDAOMADA HEALTH INC | −100.0% | −$17m | 0.3% → 0.0% | — |
| Trimmed | TNGXTANGO THERAPEUTICS INC | −20.3% | −$17m | 1.6% → 1.3% | 7 |
| New | SCTXSCRIBE THERAPEUTICS INC | New | +$17m | 0.0% → 0.3% | 4 |
| Trimmed | ZYMEZYMEWORKS INC | −15.2% | −$17m | 1.7% → 1.8% | 2 |
| Trimmed | NVCTNUVECTIS PHARMA INC | −76.0% | −$16m | 0.3% → 0.1% | 0 |
| Trimmed | DHRDANAHER CORP DEL | −53.8% | −$16m | 0.4% → 0.2% | 23 |
| New | GRALGRAIL INC | New | +$14m | 0.0% → 0.3% | 5 |
| Trimmed | IRTCIRHYTHM HOLDINGS INC | −49.2% | −$13m | 0.4% → 0.2% | 2 |
| Trimmed | TVTXTRAVERE THERAPEUTICS INC | −5.6% | −$12m | 3.3% → 3.9% | 1 |
| New | MANEVERADERMICS INC | New | +$12m | 0.0% → 0.2% | 2 |
| Sold out | OSCROSCAR HEALTH INC | −100.0% | −$11m | 0.2% → 0.0% | — |
| Sold out | BSXBOSTON SCIENTIFIC CORP | −100.0% | −$11m | 0.2% → 0.0% | — |
| Trimmed | EWTXEDGEWISE THERAPEUTICS INC | −5.4% | −$9.6m | 2.8% → 3.1% | 4 |
| Sold out | NTRANATERA INC | −100.0% | −$9.4m | 0.1% → 0.0% | — |
| Added | AORTARTIVION INC | +21.6% | +$8.6m | 0.6% → 0.9% | 0 |
| New | CAPRCAPRICOR THERAPEUTICS INC | New | +$8.0m | 0.0% → 0.2% | 3 |
| Sold out | CGEMCULLINAN THERAPEUTICS INC | −100.0% | −$7.8m | 0.1% → 0.0% | — |
| Trimmed | DBVTDBV TECHNOLOGIES S A | −31.3% | −$6.1m | 0.4% → 0.3% | 2 |
| New | ADRXADARX PHARMACEUTICALS INC | New | +$6.0m | 0.0% → 0.1% | 2 |
| Sold out | PHATPHATHOM PHARMACEUTICALS INC | −100.0% | −$5.8m | 0.1% → 0.0% | — |
| Trimmed | BBNXBETA BIONICS INC | −35.4% | −$5.6m | 0.2% → 0.2% | 2 |
| Trimmed | STROSUTRO BIOPHARMA INC | −25.6% | −$5.4m | 0.7% → 0.3% | 3 |
| Trimmed | RYTMRHYTHM PHARMACEUTICALS INC | −2.1% | −$5.1m | 4.5% → 4.5% | 3 |
| Added | GHGUARDANT HEALTH INC | +69.4% | +$5.1m | 0.1% → 0.2% | 6 |
| New | OLMAOLEMA PHARMACEUTICALS INC | New | +$5.0m | 0.0% → 0.1% | 2 |
| Sold out | COGTCOGENT BIOSCIENCES INC | −100.0% | −$4.7m | 0.1% → 0.0% | — |
| Added | RGENREPLIGEN CORP | +9.8% | +$4.7m | 0.5% → 1.0% | 2 |
| Added | XERSXERIS BIOPHARMA HOLDINGS INC | +99.9% | +$4.5m | 0.1% → 0.2% | 1 |
| Trimmed | VRDNVIRIDIAN THERAPEUTICS INC | −34.5% | −$4.1m | 0.2% → 0.1% | 6 |
| Trimmed | IVVDINVIVYD INC | −25.6% | −$4.1m | 0.3% → 0.2% | 2 |
Showing the 60 largest of 84 trades.
All holdings 85 identified, plus $743m in securities without a listed ticker
Click a column to sort. Values are as reported at quarter-end, not today's prices.
| # | Stock | Shares | ||||
|---|---|---|---|---|---|---|
| 1 | PRAXPRAXIS PRECISION MEDICINES I | $590m | 2,024,781 | −0.6% | 5 | |
| 2 | AMLXAMYLYX PHARMACEUTICALS INC | $308m | 10,573,735 | +26.9% | 2 | |
| 3 | SYRESPYRE THERAPEUTICS INC | $292m | 3,280,943 | −24.0% | 3 | |
| 4 | CELCCELCUITY INC | $253m | 3,179,794 | −0.5% | 4 | |
| 5 | RYTMRHYTHM PHARMACEUTICALS INC | $241m | 2,532,556 | −2.1% | 3 | |
| 6 | RLAYRELAY THERAPEUTICS INC | $230m | 12,730,336 | −9.8% | 3 | |
| 7 | TVTXTRAVERE THERAPEUTICS INC | $209m | 3,542,913 | −5.6% | 1 | |
| 8 | FRNMFREENOME INC | $199m | 12,606,053 | New | 4 | |
| 9 | EWTXEDGEWISE THERAPEUTICS INC | $168m | 4,138,282 | −5.4% | 4 | |
| 10 | INBXINHIBRX BIOSCIENCES INC | $129m | 1,292,463 | −0.4% | — | |
| 11 | NRIXNURIX THERAPEUTICS INC | $127m | 5,371,629 | +24.3% | 3 | |
| 12 | KARDKARDIGAN INC | $121m | 8,200,662 | Unchanged | 1 | |
| 13 | PTGXPROTAGONIST THERAPEUTICS INC | $118m | 836,579 | −14.8% | 4 | |
| 14 | ZYMEZYMEWORKS INC | $94m | 3,545,501 | −15.2% | 2 | |
| 15 | ORKAORUKA THERAPEUTICS INC | $89m | 1,072,363 | −20.3% | 5 | |
| 16 | RVMDREVOLUTION MEDICINES INC | $89m | 433,100 | −17.9% | 8 | |
| 17 | SLDBSOLID BIOSCIENCES INC | $86m | 11,906,646 | Unchanged | 2 | |
| 18 | BCRXBIOCRYST PHARMACEUTICALS INC | $86m | 10,301,888 | −0.1% | 4 | |
| 19 | AVLNAVALYN PHARMACEUTICALS INC | $76m | 2,675,296 | Unchanged | 5 | |
| 20 | TNGXTANGO THERAPEUTICS INC | $67m | 2,693,000 | −20.3% | 7 | |
| 21 | WATWATERS CORP | $59m | 135,000 | New | 13 | |
| 22 | RGENREPLIGEN CORP | $52m | 272,456 | +9.8% | 2 | |
| 23 | AORTARTIVION INC | $48m | 2,112,290 | +21.6% | — | |
| 24 | ANROALTO NEUROSCIENCE INC | $45m | 1,760,950 | +9.4% | — | |
| 25 | IRDOPUS GENETICS INC | $44m | 9,000,000 | New | — | |
| 26 | LKFTLAKEFRONT BIOTHERAPEUTICS NV | $37m | 1,242,404 | New | 1 | |
| 27 | ABTABBOTT LABORATORIES | $34m | 345,225 | New | 15 | |
| 28 | BLSMBLOSSOMHILL THERAPEUTICS INC | $34m | 1,812,193 | New | 1 | |
| 29 | OBIOORCHESTRA BIOMED HLDGS INC | $31m | 5,037,606 | 0.0% | 1 | |
| 30 | CRVSCORVUS PHARMACEUTICALS INC | $29m | 2,510,441 | −5.9% | — | |
| 31 | AVRANTERIS TECHNOLOGIES GLOBAL | $27m | 3,425,476 | Unchanged | 4 | |
| 32 | ANLADLAI NORTYE GROUP LTD | $27m | 1,660,502 | −7.4% | — | |
| 33 | MMEDMINIMED GROUP INC | $26m | 1,320,000 | New | 1 | |
| 34 | CTMXCYTOMX THERAPEUTICS INC. | $25m | 9,268,061 | −11.2% | 2 | |
| 35 | RAPPRAPPORT THERAPEUTICS INC | $24m | 724,342 | −6.3% | 1 | |
| 36 | SEPNSEPTERNA INC | $22m | 567,479 | New | 2 | |
| 37 | XFORX4 PHARMACEUTICALS INC | $21m | 7,350,491 | −7.3% | 1 | |
| 38 | ELVNENLIVEN THERAPEUTICS INC | $21m | 462,506 | New | 3 | |
| 39 | SABSSAB BIOTHERAPEUTICS INC | $21m | 6,627,501 | Unchanged | 2 | |
| 40 | DYNDYNE THERAPEUTICS INC | $20m | 1,265,362 | −52.9% | 5 | |
| 41 | EOLSEVOLUS INC | $20m | 2,459,285 | Unchanged | 1 | |
| 42 | YARWYARROW BIOSCIENCE INC | $18m | 813,098 | New | — | |
| 43 | IMVTIMMUNOVANT INC | $18m | 519,345 | −61.7% | 5 | |
| 44 | SCTXSCRIBE THERAPEUTICS INC | $17m | 920,341 | New | 4 | |
| 45 | NAUTNAUTILUS BIOTECHNOLOGY INC | $16m | 11,564,744 | −0.6% | — | |
| 46 | STROSUTRO BIOPHARMA INC | $16m | 970,846 | −25.6% | 3 | |
| 47 | SRZNSURROZEN INC | $14m | 439,685 | −12.8% | 1 | |
| 48 | GRALGRAIL INC | $14m | 96,911 | New | 5 | |
| 49 | DBVTDBV TECHNOLOGIES S A | $13m | 1,136,534 | −31.3% | 2 | |
| 50 | DHRDANAHER CORP DEL | $13m | 60,000 | −53.8% | 23 | |
| 51 | IRTCIRHYTHM HOLDINGS INC | $13m | 113,766 | −49.2% | 2 | |
| 52 | GHGUARDANT HEALTH INC | $12m | 70,000 | +69.4% | 6 | |
| 53 | IVVDINVIVYD INC | $12m | 13,762,637 | −25.6% | 2 | |
| 54 | ADPTADAPTIVE BIOTECHNOLOGIES COR | $12m | 412,325 | −66.1% | 1 | |
| 55 | MANEVERADERMICS INC | $12m | 97,000 | New | 2 | |
| 56 | AXGNAXOGEN INC | $12m | 280,000 | +13.2% | 2 | |
| 57 | PALIPALISADE BIO INC | $11m | 8,425,065 | Unchanged | 2 | |
| 58 | BBNXBETA BIONICS INC | $10m | 538,159 | −35.4% | 2 | |
| 59 | SPTXSEAPORT THERAPEUTICS INC | $10m | 500,000 | Unchanged | 2 | |
| 60 | MIRMMIRUM PHARMACEUTICALS INC | $9.9m | 115,391 | Unchanged | 8 | |
| 61 | XERSXERIS BIOPHARMA HOLDINGS INC | $8.9m | 933,671 | +99.9% | 1 | |
| 62 | CAPRCAPRICOR THERAPEUTICS INC | $8.0m | 850,000 | New | 3 | |
| 63 | VRDNVIRIDIAN THERAPEUTICS INC | $7.9m | 381,452 | −34.5% | 6 | |
| 64 | ABVXABIVAX SA | $7.3m | 74,000 | Unchanged | 6 | |
| 65 | ENGNENGENE THERAPEUTICS INC | $7.0m | 3,482,169 | −27.8% | — | |
| 66 | BLLNBILLIONTOONE INC | $6.9m | 65,209 | −24.9% | 2 | |
| 67 | AGMBAGOMAB THERAPEUTICS NV | $6.7m | 600,000 | Unchanged | 1 | |
| 68 | LONALEONABIO INC | $6.6m | 1,859,322 | Unchanged | 1 | |
| 69 | BIIBBIOGEN INC | $6.3m | 28,030 | −89.9% | 3 | |
| 70 | ADRXADARX PHARMACEUTICALS INC | $6.0m | 300,000 | New | 2 | |
| 71 | NVCTNUVECTIS PHARMA INC | $5.1m | 240,000 | −76.0% | — | |
| 72 | OLMAOLEMA PHARMACEUTICALS INC | $5.0m | 575,000 | New | 2 | |
| 73 | UNHUNITEDHEALTH GROUP INC | $3.7m | 10,000 | −91.4% | 27 | |
| 74 | MOBIMOBIA MED INC | $3.2m | 343,654 | −34.4% | 1 | |
| 75 | OMOUTSET MED INC | $2.5m | 833,333 | Unchanged | 1 | |
| 76 | CBLLCERIBELL INC | $2.4m | 98,779 | New | 1 | |
| 77 | EDSAEDESA BIOTECH INC | $2.4m | 563,239 | Unchanged | 1 | |
| 78 | BRVEBRAVEHEART BIO INC | $2.3m | 115,000 | New | 4 | |
| 79 | OTLKOUTLOOK THERAPEUTICS INC | $1.8m | 3,139,216 | Unchanged | 1 | |
| 80 | ADMAADMA BIOLOGICS INC | $1.1m | 113,765 | Unchanged | 2 | |
| 81 | KPRXKIORA PHARMACEUTICALS INC | $1.1m | 438,471 | Unchanged | — | |
| 82 | MDLNMEDLINE INC | $972k | 28,000 | Unchanged | 8 | |
| 83 | XGNEXAGEN INC | $934k | 114,893 | Unchanged | — | |
| 84 | SGMTSAGIMET BIOSCIENCES INC | $669k | 67,674 | New | 3 | |
| 85 | ENSCENSYSCE BIOSCIENCES INC | $36k | 86,666 | Unchanged | — |
Closest portfolios
Overlap is the weight two books have in common: for each shared stock, the smaller of the two weights, summed.
- TCG Crossover Management16.0%12 shared · AMLX, SYRE, RLAY, BCRX
- Ra Capital Management15.6%19 shared · RYTM, EWTX, FRNM, ORKA
- Rtw Investments15.1%22 shared · SYRE, CELC, PTGX, ORKA
- Paradigm Biocapital Advisors13.9%9 shared · SYRE, EWTX, ORKA, RVMD
- Deerfield Management12.8%9 shared · PRAX, CELC, RVMD, BCRX
- Baker Bros. Advisors11.6%19 shared · RYTM, PRAX, CELC, RVMD
- Farallon Capital Management5.9%14 shared · PTGX, RVMD, TNGX, IMVT
- Novo Holdings5.7%6 shared · EWTX, AVLN, ELVN, DYN
- Bvf4.9%9 shared · ZYME, RVMD, AVR, STRO
- Avoro Capital Advisors4.0%7 shared · RVMD, CELC, SEPN, SCTX
Only here
The largest holdings no other tracked guru owns.
- INBXINHIBRX BIOSCIENCES INC2.4%
- AORTARTIVION INC0.9%
- ANROALTO NEUROSCIENCE INC0.8%
- IRDOPUS GENETICS INC0.8%
- CRVSCORVUS PHARMACEUTICALS INC0.5%
- ANLADLAI NORTYE GROUP LTD0.5%
- YARWYARROW BIOSCIENCE INC0.3%
- NAUTNAUTILUS BIOTECHNOLOGY INC0.3%
- ENGNENGENE THERAPEUTICS INC0.1%
- NVCTNUVECTIS PHARMA INC0.1%
- KPRXKIORA PHARMACEUTICALS INC0.0%
- XGNEXAGEN INC0.0%
A 13F is a filing, not a live portfolio. It lists US-listed long stock positions at quarter-end, and it arrives up to 45 days later. Cash, shorts, bonds, options and foreign listings are not in it. Trade sizes here are estimates from the change in share count, restated for stock splits.
Snapshot refreshed